Results 31 to 40 of about 268,622 (261)

Angioarchitectural evolution of clival dural arteriovenous fistulas in two patients. [PDF]

open access: yes, 2015
Dural arteriovenous fistulas (dAVFs) may present in a variety of ways, including as carotid-cavernous sinus fistulas. The ophthalmologic sequelae of carotid-cavernous sinus fistulas are known and recognizable, but less commonly seen is the rare clival ...
Amar, Arun P   +5 more
core   +3 more sources

Changes in the gut microbiota of patients with Graves' orbitopathy according to severity grade

open access: yesClinical and Experimental Ophthalmology, 2023
To explore the changes of gut microbiota in Graves' orbitopathy (GO) patients of different severity grades and to identify the pathogenic bacteria of GO and the associated mechanism.
Qianshi Zhang   +7 more
semanticscholar   +1 more source

A rare case of severe bilateral Graves’ orbitopathy involving an anophthalmic socket

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2023
This is a report of a rare case of Graves’ hyperthyroidism associated with severe bilateral Graves’ orbitopathy, in a patient with an anophthalmic eye socket.
Mudassir Ali   +6 more
doaj   +1 more source

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis

open access: yesTürk Oftalmoloji Dergisi, 2017
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients.
Tülay Şimşek   +3 more
doaj   +1 more source

Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications [PDF]

open access: yes, 2019
Background: Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Diabetes mellitus (DM) has been reported to be a risk factor in patients with GO.
Biondi, B   +5 more
core   +2 more sources

High IgG4 serum concentration is associated with active Graves orbitopathy

open access: yesFrontiers in Endocrinology, 2023
Background The aim of the study was to evaluate the differences in clinical profile, laboratory parameters, and ophthalmological signs, and symptoms between patients with high IgG4 Graves orbitopathy and patients with normal IgG4 Graves orbitopathy ...
Michał Olejarz   +7 more
semanticscholar   +1 more source

Results after En Bloc Lateral Wall Decompression Surgery with Orbital Fat Resection in 111 Patients with Graves’ Orbitopathy

open access: yesInternational Journal of Endocrinology, 2015
Purpose. To evaluate the effect of en bloc lateral wall decompression with additional orbital fat resection in terms of exophthalmos reduction and complications. Methods.
Nicole Fichter, Rudolf F. Guthoff
doaj   +1 more source

Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-[béta] in orbital fibroblasts [PDF]

open access: yes, 2018
L
Berta, Eszter   +10 more
core   +1 more source

Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. [PDF]

open access: yes, 2018
Thyroid-associated orbitopathy (TAO) is the most common autoimmune disease of the orbit. It occurs more often in patients presenting with hyperthyroidism, characteristic of Graves' disease, but may be associated with hypothyroidism or euthyroidism.
De Los Angeles Gracia, M.   +4 more
core   +3 more sources

Inactive Graves’ orbitopathy: to treat or not to treat?

open access: yesРоссийский офтальмологический журнал, 2023
Purpose: to evaluate the expediency and efficacy of conservative therapy of patients with inactive stages of Graves’ orbitopathy complicated by optical neuropathy. Materials and methods.
O. G. Panteleeva, F. H. Batyrbekova
doaj   +1 more source

Home - About - Disclaimer - Privacy